Life Sci 197:4655 Hidalgo Santiago JC, Maraver Delgado J, Cayn Blanco M, Lpez Saez JB, Gmez-Fernndez P (2020) Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus
Daily oral orforglipron (Foundayo): Weekly injectable semaglutide for weight loss (Wegovy) : Average weight loss of 14.9 percent of body weight after about 15 months, compared with 2.4 percent in a placebo group Average weight loss of 21 percent of body weight after about 16 months, compared with 3.1 percent in a placebo group Weekly injectable tirzepatide for weight loss (Zepbound): Secondary Health Benefits Though this entire family of drugs has benefits for metabolic health, not every particular drug has been approved for the same conditions
"In all the articles that we read about the pelvic floor, and everyone's like, 'Just do Kegels...' Kegels aren't right for everybody, but diaphragmatic breathing is right for everybody.
While plaintiffs push for access to Novo Nordisks internal safety records and adverse event data, the defense is expected to challenge claims regarding medical causation